This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

2013 Projected Global Laboratory Products Budgets

NEW YORK, March 21, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

2013 Projected Global Laboratory Products Budgets

This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents and kits, glassware, plasticware, and general laboratory supplies over the 2011-2013 period. Budgets for service and repair of instruments and equipment also are presented. Additionally, respondents name the brands that are top-of-mind (unaided brand recognition) in each of the seven product categories. Finally, by-laboratory-type analyses are presented. The lab types examined are: academic, biopharmaceutical, industrial, patient care, and government.

Executive Summary

This study is based on a survey of researchers working in laboratories of various types worldwide. However, most respondents work in the United States. All professed at least some degree of familiarity with their lab's budget.

With the 'fiscal cliff' looming, the possibility that substantial portions of the U.S. federal budget will be trimmed in 2013, laboratories that depend on government money are anticipating sharply constrained budgets. Other labs may also be affected due to the negative impact that lower federal spending and higher taxes would have on the overall economy. Thus, instead of the once-typical growth of to percent, overall growth of just percent is anticipated for 2013, after percent growth in 2012.

Budget growth rates realized in 2012 and anticipated for 2013 differ substantially across laboratory and product type, as illustrated throughout the body of this research. Academic labs expect budget growth of percent, after a percent decline in 2012. All other lab types expect slower growth in 2013 than in 2012. However, because of the large share of academic labs in the sample, overall budget growth across all lab and product types is expected to increase slightly.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.30 -0.92%
FB $118.08 0.55%
GOOG $695.81 0.50%
TSLA $234.18 0.80%
YHOO $35.97 -0.11%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs